Michael Gelband’s Cerence CRNC Stock Holding History

Michael Gelband’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,060	Closed	-$95K	–	1648
2026 Q1	$95K	Sell	15,060 -7,516	-33%	-$67.7K	﹤0.01%	1439
2025 Q4	$241K	Buy	+22,576	New	+$248K	﹤0.01%	1358
2024 Q1	–	Sell	-75,234	Closed	-$1.48M	–	1570
2023 Q4	$1.48M	Buy	+75,234	New	+$1.31M	0.01%	673
2022 Q1	–	Sell	-7,311	Closed	-$560K	–	2267
2021 Q4	$560K	Buy	+7,311	New	+$645K	0.01%	1338
2021 Q3	–	Sell	-58,537	Closed	-$6.25M	–	2193
2021 Q2	$6.25M	Buy	58,537 +52,476	+866%	+$5.16M	0.07%	271
2021 Q1	$543K	Buy	6,061 +3,565	+143%	+$392K	0.01%	1291
2020 Q4	$251K	Buy	+2,496	New	+$186K	﹤0.01%	1621
2020 Q3	–	Sell	-9,241	Closed	-$377K	–	1817
2020 Q2	$377K	Sell	9,241 -76,898	-89%	-$2.21M	0.01%	1205
2020 Q1	$1.33M	Buy	86,139 +28,045	+48%	+$589K	0.07%	247
2019 Q4	$1.31M	Buy	+58,094	New	+$953K	0.02%	455

Other funds holding CRNC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

ACM

American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

OFCM

One Fin Capital Management San Francisco, California $310M AUM 45.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Michael Gelband's CRNC Position: Q2 2026 in Review

Michael Gelband sold out of Cerence (CRNC) in Q2 2026, closing a stake of 15,060 shares — an estimated $95K sold.

Michael Gelband first reported a position in CRNC in Q4 2019 and held it in 10 quarters. The position peaked at $6.25M in Q2 2021. 193 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

Michael Gelband reported no remaining Cerence position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 15,060 Cerence shares in Q2 2026, an estimated $95K.
Michael Gelband first reported a position in Cerence in Q4 2019 and held it in 10 quarters.
Michael Gelband's Cerence position peaked at $6.25M in Q2 2021.
193 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.